Joseph Brougham is currently an Executive Medical Science Liaison in Thoracic Oncology at AstraZeneca, having transitioned to this role in 2022 after serving as a Senior Medical Science Liaison in the same field from 2015 to 2022. Prior to their time at AstraZeneca, Joseph worked at Bristol-Myers Squibb as a Medical Science Liaison in Oncology from 2007 to 2013, where they engaged healthcare providers in clinical discussions and scientific activities. Joseph's experience also includes positions as an Oncology Scientific Director at Merck and a Medical Liaison at Novo Nordisk A/S. Joseph earned a Bachelor of Science in Biochemistry from the University of Northern Colorado and a Doctor of Pharmacy degree from the University of Colorado at Denver.
This person is not in the org chart
This person is not in any teams
This person is not in any offices